Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease

Introduction. Although 90% of prostate cancer is considered to be localized, 20%–30% of patients will experience biochemical failure (BF), defined as serum PSA >0.2 ng/mL, after radical prostatectomy (RP). The presence of circulating prostate cells (CPCs) in men without evidence of BF may be usef...

Full description

Saved in:
Bibliographic Details
Main Authors: Nigel P. Murray, Eduardo Reyes, Nelson Orellana, Cynthia Fuentealba, Leonardo Bádinez, Ruben Olivares, José Porcell, Ricardo Dueñas
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2013/762064
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561615631810560
author Nigel P. Murray
Eduardo Reyes
Nelson Orellana
Cynthia Fuentealba
Leonardo Bádinez
Ruben Olivares
José Porcell
Ricardo Dueñas
author_facet Nigel P. Murray
Eduardo Reyes
Nelson Orellana
Cynthia Fuentealba
Leonardo Bádinez
Ruben Olivares
José Porcell
Ricardo Dueñas
author_sort Nigel P. Murray
collection DOAJ
description Introduction. Although 90% of prostate cancer is considered to be localized, 20%–30% of patients will experience biochemical failure (BF), defined as serum PSA >0.2 ng/mL, after radical prostatectomy (RP). The presence of circulating prostate cells (CPCs) in men without evidence of BF may be useful to predict patients at risk for BF. We describe the frequency of CPCs detected after RP, relation with clinicopathological parameters, and association with biochemical failure. Methods and Patients. Serial blood samples were taken during followup after RP, mononuclear cells were obtained by differential gel centrifugation, and CPCs identified using standard immunocytochemistry using anti-PSA monoclonal antibodies. Age, pathological stage (organ confined, nonorgan confined), pathological grade, margin status (positive, negative), extracapsular extension, perineural, vascular, and lymphatic infiltration (positive, negative) were compared with the presence/absence of CPCs and with and without biochemical failure. Kaplan Meier methods were used to compare the unadjusted biochemical failure free survival of patients with and without CPCs. Results. 114 men participated, and secondary CPCs were detected more frequently in patients with positive margins, extracapsular extension, and vascular and lymphatic infiltration and were associated with biochemical failure independent of these clinicopathological variables, and with a shorter time to BF. Conclusions. Secondary CPCs are an independent risk factor associated with increased BF in men with a PSA <0.2 ng/mL after radical prostatectomy, but do not determine if the recurrence is due to local or systemic disease. These results warrant larger studies to confirm the findings.
format Article
id doaj-art-145a93b0d6334a8e9f6f6e2d7a84cefb
institution Kabale University
issn 1537-744X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-145a93b0d6334a8e9f6f6e2d7a84cefb2025-02-03T01:24:32ZengWileyThe Scientific World Journal1537-744X2013-01-01201310.1155/2013/762064762064Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of DiseaseNigel P. Murray0Eduardo Reyes1Nelson Orellana2Cynthia Fuentealba3Leonardo Bádinez4Ruben Olivares5José Porcell6Ricardo Dueñas7Division of Medicine, Hospital de Carabineros de Chile, Simón Bolívar 2200, Ñuñoa, 7770199 Santiago, ChileFaculty of Medicine, Universidad Diego Portales, Manuel Rodriguez Sur 415, 8370179 Santiago, ChileUrology Division, Hospital de Carabineros de Chile, Simón Bolívar 2200, Ñuñoa, 7770199 Santiago, ChileUrology Division, Hospital de Carabineros de Chile, Simón Bolívar 2200, Ñuñoa, 7770199 Santiago, ChileFoundation Arturo Lopez Perez, Rancagua 899, Providencia, 7500921 Santiago, ChileUrology Division, Hospital de Carabineros de Chile, Simón Bolívar 2200, Ñuñoa, 7770199 Santiago, ChileDivision of Medicine, Hospital de Carabineros de Chile, Simón Bolívar 2200, Ñuñoa, 7770199 Santiago, ChileUrology Division, Hospital de Carabineros de Chile, Simón Bolívar 2200, Ñuñoa, 7770199 Santiago, ChileIntroduction. Although 90% of prostate cancer is considered to be localized, 20%–30% of patients will experience biochemical failure (BF), defined as serum PSA >0.2 ng/mL, after radical prostatectomy (RP). The presence of circulating prostate cells (CPCs) in men without evidence of BF may be useful to predict patients at risk for BF. We describe the frequency of CPCs detected after RP, relation with clinicopathological parameters, and association with biochemical failure. Methods and Patients. Serial blood samples were taken during followup after RP, mononuclear cells were obtained by differential gel centrifugation, and CPCs identified using standard immunocytochemistry using anti-PSA monoclonal antibodies. Age, pathological stage (organ confined, nonorgan confined), pathological grade, margin status (positive, negative), extracapsular extension, perineural, vascular, and lymphatic infiltration (positive, negative) were compared with the presence/absence of CPCs and with and without biochemical failure. Kaplan Meier methods were used to compare the unadjusted biochemical failure free survival of patients with and without CPCs. Results. 114 men participated, and secondary CPCs were detected more frequently in patients with positive margins, extracapsular extension, and vascular and lymphatic infiltration and were associated with biochemical failure independent of these clinicopathological variables, and with a shorter time to BF. Conclusions. Secondary CPCs are an independent risk factor associated with increased BF in men with a PSA <0.2 ng/mL after radical prostatectomy, but do not determine if the recurrence is due to local or systemic disease. These results warrant larger studies to confirm the findings.http://dx.doi.org/10.1155/2013/762064
spellingShingle Nigel P. Murray
Eduardo Reyes
Nelson Orellana
Cynthia Fuentealba
Leonardo Bádinez
Ruben Olivares
José Porcell
Ricardo Dueñas
Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease
The Scientific World Journal
title Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease
title_full Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease
title_fullStr Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease
title_full_unstemmed Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease
title_short Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease
title_sort secondary circulating prostate cells predict biochemical failure in prostate cancer patients after radical prostatectomy and without evidence of disease
url http://dx.doi.org/10.1155/2013/762064
work_keys_str_mv AT nigelpmurray secondarycirculatingprostatecellspredictbiochemicalfailureinprostatecancerpatientsafterradicalprostatectomyandwithoutevidenceofdisease
AT eduardoreyes secondarycirculatingprostatecellspredictbiochemicalfailureinprostatecancerpatientsafterradicalprostatectomyandwithoutevidenceofdisease
AT nelsonorellana secondarycirculatingprostatecellspredictbiochemicalfailureinprostatecancerpatientsafterradicalprostatectomyandwithoutevidenceofdisease
AT cynthiafuentealba secondarycirculatingprostatecellspredictbiochemicalfailureinprostatecancerpatientsafterradicalprostatectomyandwithoutevidenceofdisease
AT leonardobadinez secondarycirculatingprostatecellspredictbiochemicalfailureinprostatecancerpatientsafterradicalprostatectomyandwithoutevidenceofdisease
AT rubenolivares secondarycirculatingprostatecellspredictbiochemicalfailureinprostatecancerpatientsafterradicalprostatectomyandwithoutevidenceofdisease
AT joseporcell secondarycirculatingprostatecellspredictbiochemicalfailureinprostatecancerpatientsafterradicalprostatectomyandwithoutevidenceofdisease
AT ricardoduenas secondarycirculatingprostatecellspredictbiochemicalfailureinprostatecancerpatientsafterradicalprostatectomyandwithoutevidenceofdisease